Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Onecell Diagnostics India Private Limited, is an unlisted private company incorporated on 20 December, 2021. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 1.00 lac and the total paid-up capital is INR 1.00 lac.
Onecell Diagnostics India's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 15746.17% over the previous year. At the same time, it's book networth has increased by 82.54%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2023 numbers.
-13.83%
-15746.17%
1.35%
82.54%
-100.0%
88.51%
-244.52
-731.72
-2.39
-36.23
-10183.44
-9.26
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
Latest financials
Latest annual return
MoA and AoA
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Dec 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Dec 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Dec 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Dec 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Vijay Prabhakarrao Uttarwar | 00239028 | 3 years |
| Director | Jayant Jagannath Khandare | 06585502 | 3 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| INDX TECHNOLOGY (INDIA) PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| UTTARWAR CHARITABLE FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
| BIOIMAGENE INDIA PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| INDX LIFECARE (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| BIOIMAGENE INDIA LLP |
Active
|
1.0 L | 1 | Maharashtra |
| NATURELL (INDIA) PRIVATE LIMITED |
Active
|
1.5 Cr | 1 | Maharashtra |
| CANVIN INNOVATION PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| ACTORIUS INNOVATIONS AND RESEARCH PRIVATE LIMITED |
Active
|
1.6 L | 1 | Maharashtra |
| RIGHT TO RESEARCH FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
| SOLUTIONS IN INNOVATIVE RESEARCH PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| PRECISION ONCOLOGY FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
| ADMATIUS INNOVATIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
The incorporation date of ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED is 20 December, 2021
The authorized share capital of ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED is Eternelle Flat No. A-602, Sr. No. 86 Nr. Anjor Society Pune Pune Maharashtra - 411045
The CIN number of ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED is U85100PN2021PTC207038.
Expand
Delete
Collapse
See
details
